Cheryl Shoubridge

Associate Professor Cheryl Shoubridge is a Senior Research Fellow in the School of Biomedicine at the University of Adelaide's Faculty of Health and Medical Sciences. Her research focuses on identifying genetic causes and molecular mechanisms underlying intellectual disabilities, autism spectrum disorders, and epilepsies. She leads the Intellectual Disability Research Laboratory, which investigates genes such as ARX and IQSEC2 using primary neuronal cell cultures and animal models. Her work aims to understand how genetic mutations impact brain development and function, with a focus on developing therapeutic strategies.

Current research projects include evaluating drug treatments for IQSEC2-associated disorders and exploring the effects of early 17β-estradiol treatment on seizure reduction in genetic mouse models. Dr. Shoubridge also collaborates on healthcare interventions addressing unmet social needs in vulnerable populations, including pediatric caregivers and cancer patients. She is eligible to supervise Masters and PhD students in neurogenetics and translational research.

Her laboratory's location is at the Adelaide Health and Medical Sciences building on North Terrace. Research interests span neurodevelopmental disorders, gene expression analysis, and the application of genomic technologies to clinical diagnostics. While no awards are explicitly mentioned in the provided materials, her contributions to understanding X-linked intellectual disability mechanisms are internationally recognized.

Dr. Shoubridge’s work bridges basic science and clinical translation, with recent projects addressing maternal aging impacts on offspring health and socioeconomic disparities in healthcare access. Her team’s interdisciplinary approach integrates molecular biology, translational medicine, and public health initiatives to advance both disease understanding and patient care.